Uppal Abhineet, Ferguson Mark K, Posner Mitchell C, Hellman Samuel, Khodarev Nikolai N, Weichselbaum Ralph R
Department of Surgery, The University of Chicago, MC 5029, 5841 S. Maryland Ave, Chicago, IL, 60637, USA,
Clin Exp Metastasis. 2014 Aug;31(6):735-48. doi: 10.1007/s10585-014-9664-3. Epub 2014 Jun 27.
Oligometastasis is a cancer disease state characterized by a limited number of metastatic tumors involving single or few organs and with biological properties that make them potentially amenable to locoregional antitumor therapy. Current clinical data show that they are potentially curable with surgical resection or/and radiotherapy. Yet, mechanisms of progression from primary tumor to oligometastasis, rather than to polymetastases, is lacking in detail. In the current review we focus on the role of micro-RNAs in the regulation of metastases development and the role they may play in the differentiation of oligometastatic from polymetastatic progression. We also discuss the analyses of metastatic samples from oligo-and polymetastatic patients, which suggest that oligometastasis is a distinct biologic entity regulated in part by micro-RNAs. In addition, a review of the known functions of oligometastatic-specific micro-RNAs suggest that they regulate multiple steps in the metastatic cascade, including epithelial-mesenchymal transition, tumor invasion, intravasation, distant vascular extravasation and proliferation in a distant organ. Understanding the role of micro-RNAs and their target genes in oligometastatic disease may allow for the development of targeted therapies to effectively conrol the spread of metastases.
寡转移是一种癌症疾病状态,其特征为转移瘤数量有限,累及单个或少数器官,且具有使其可能适合局部抗肿瘤治疗的生物学特性。目前的临床数据表明,通过手术切除或/和放疗,它们有可能被治愈。然而,原发性肿瘤发展为寡转移而非多转移的机制尚缺乏详细研究。在本综述中,我们重点关注微小RNA在转移发展调控中的作用以及它们在寡转移与多转移进展分化中可能发挥的作用。我们还讨论了对寡转移和多转移患者转移样本的分析,这些分析表明寡转移是一种独特的生物学实体,部分受微小RNA调控。此外,对寡转移特异性微小RNA已知功能的综述表明,它们在转移级联反应的多个步骤中发挥调节作用,包括上皮-间质转化、肿瘤侵袭、血管内渗、远处血管外渗以及在远处器官中的增殖。了解微小RNA及其靶基因在寡转移疾病中的作用可能有助于开发靶向疗法,以有效控制转移的扩散。